Lakeland Industries, Inc. (LAKE) And Alpha Pro Tech, Ltd. (APT) Have Huge Potential With Their Protective Solutions For Ebola

The continued fears of Ebola have boosted the shares of companies indulged in protective clothing manufacturing. The shares of Lakeland Industries, Inc. (NASDAQ:LAKE) and Alpha Pro Tech, Ltd. (NYSEMKT:APT) witnessed an upward trend after the likeliness of heightened demand  of protective wear.

Lakeland Industries (LAKE)

The shares of Lakeland Industries, Inc. (NASDAQ:LAKE) rose up to 10.78% on Friday considering an increase in protective suit demand and its share prices grew up to 125% in the last one week. The company has listed special protective suit, ChemMax 1, with sealed seams and it serves well in dangerous environments such as taking care of Ebola patients. Further, the company dedicated a specific part of its website to “Ebola” outbreak and relevant information.

Alpha Pro Tech, Ltd. (NYSEMKT:APT) witnessed an increase of 53.51% in its shares on Friday closing at $7.43. Alpha Pro is involved in the manufacturing of facemasks, protective hoods, lab coats, and gowns.

The Ebola outbreak has killed as many as 3,800 people in West Africa with affected populace of nearly 8,000, as per WHO records. At the same time, USA and other countries are practicing precautionary measures against the disease. The worst part of the equation is that there are no certified drugs available for the treatment of Ebola virus.

Some of the leading companies working in Ebola treatment include Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), Sarepta Therapeutics Inc (NASDAQ:SRPT), and BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) came up with TKM-Ebola vaccine, which has been approved by both FDA and Health Canada for Ebola treatment.

Sarepta Therapeutics Inc (NASDAQ:SRPT), and BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) are the two other companies with some conclusive leads in Ebola treatment. Sarepta Therapeutics announced earlier that it has up to 100 doses for Ebola treatment and BioCryst Pharmaceuticals is likely to begin trials on Ebola soon enough.

Tekmira Pharmaceuticals Corporation (TKMR), BioCryst Pharmaceuticals, Inc. (BCRX), Sarepta Therapeutics Inc (SRPT) Lead Ebola Treatment Campaign

GlaxoSmithKline plc (ADR) (GSK) Vaccine for Ebola Exhibits Positive Results in Monkey Tests

Read: The 10 Most Suicidal Cities in America


Warren Buffett's Best Picks

Warren Buffett's these stock picks will crush the market over the next 12 months. Get our report FREE by becoming a member now